3D Systems Accelerates Growth in Aerospace & Defense with Strategic Investments and Projected Leadership Position Aerospace & Defense on Track to Become Company's Largest Industrial Business in 2026, Supported by Ongoing Investments and Favorable U.S. Policy Tailwinds GlobeNewswire January 05, 2026 ROCK HILL, S.C., Jan. 05, 2026 (GLOBE NEWSWIRE) — 3D Systems (NYSE: DDD), a […]
Copperhead Resources Announces Changes in Officers GlobeNewswire January 05, 2026 Vancouver, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) — Copperhead Resources Inc. (CSE: CUH) (“Copperhead” or the “Company”) announces that Kevin Zhou has resigned as an officer of the Company. The Company thanks Mr. Zhou for his contributions and service. The Company is also pleased
Angitia Biopharmaceuticals Completes Enrollment of Phase 2 ARTEMIS Trial Evaluating AGA2118 for the Treatment of Osteoporosis GlobeNewswire January 05, 2026 – Company expects topline data from the study in 2027 WESTLAKE VILLAGE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 05, 2026 NORWOOD, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview at
AMC Robotics Establishes Vietnam Subsidiary to Expand Local Partnerships and Support Robotics Manufacturing GlobeNewswire January 05, 2026 NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), an AI-driven robotics solutions company, today announced the establishment of a Vietnamese wholly owned subsidiary with its operations to be
BridgeBio to Participate in the J.P. Morgan Healthcare Conference GlobeNewswire January 05, 2026 PALO ALTO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that co-founder and CEO, Neil Kumar, Ph.D., will present at the 44th
TERRA CLEAN PROVIDES CORPORATE UPDATE AND WELCOMES THE UNITED STATES DEPARTMENT OF ENERGY'S RECENT NEW DOMESTIC NUCLEAR FUEL SUPPLY CHAIN & URANIUM FOCUS GlobeNewswire January 05, 2026 Vancouver B.C., Jan. 05, 2026 (GLOBE NEWSWIRE) — TERRA CLEAN ENERGY CORP. (“Terra” or the “Company“) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0) welcomes the recent U.S. Department of
Enviri Announces Chief Financial Officer Tom Vadaketh's Retirement and Plans to Appoint Pete Minan as New Enviri CFO GlobeNewswire January 05, 2026 Tom Vadaketh will retire following the Clean Earth sale and spin-off of New Enviri that is expected mid-year Former Enviri CFO, Pete Minan, will bring finance industry experience and deep understanding of Enviri
Pelthos Therapeutics Acquires Xeglyze(R) (abametapir) Topical Treatment for Head Lice GlobeNewswire January 05, 2026 Acquisition adds complementary asset to the Pelthos commercial portfolio Xeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age and older DURHAM, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) —
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates The Company enters 2026 with Multiple Phase 2 Catalysts collectively representing ~$8 billion in potential market opportunities, an AI-enabled development strategy, and regulatory optionality GlobeNewswire January 05, 2026 PHILADELPHIA, Jan. 05, 2026 (GLOBE NEWSWIRE)